Prostate cancer is the second-leading cause of cancer deaths in American men. Further, non-Hispanic Blacks have a higher ...

A new study has revealed that men who don't heed recommendations for prostate cancer screenings are at a significantly higher ...

Scientists at the UCLA Health Jonsson Comprehensive Cancer Center and the University of Toronto have revealed how a tiny ...

Men who consistently avoid prostate cancer screening appointments face a disproportionately higher risk of dying from the disease, finds research identifying a new high-risk group.

Researchers evaluated links between lifestyle and dietary index scores and risk of death in a prospective, multiethnic cohort of men diagnosed with non-metastatic prostate cancer.

Monte Rosa Therapeutics’ plan to develop a molecular glue degrader in a wide range of cancers has come unstuck. | Monte Rosa ...

Former prime minister Rishi Sunak has said he is "honoured" to become a prostate cancer charity ambassador. He will support Prostate Cancer Research's campaign to introduce a national screening ...

Traditionally, men who chose radiation therapy for prostate cancer undergo radiation for weeks or even months. But now, in certain cases, it can be completed in less than a week. Prostate cancer ...

Prostate cancer is a type of malignancy that arises in the prostate gland. Prostate cancer tends to develop in older men, aged 50 and over. In many cases prostate cancer develops slowly ...

Lupron is a drug doctors prescribe to treat prostate cancer. It works by reducing testosterone levels in the body, slowing cancer growth. Lupron is the brand name for leuprolide acetate.

Years later I learned the U.S. Preventative Services Task Force (USPSTF) issued definitive guidelines in 2012 not to screen ...